GREAT NEWS TODAY for women who need to be tested for the breast cancer gene: The Supreme Court ruled today against Myriad’s patent for BRCA1/2. This is big news! Several clinical labs have already validated testing over the last few months in anticipation. Prices have been cut almost by half! Moreover, some labs are offering BRCA1/2 testing as part of Next Generation sequencing panels that include additional breast cancer genes. Probably test results will be available sooner too. Great news!
Posted on: Thu, 13 Jun 2013 20:56:51 +0000
Trending Topics
Recently Viewed Topics
© 2015